Capricor Therapeutics CAPR
NASDAQ CAPR
$9.88 +1.31 (+15.23%)
As of: Sep 30, 2026 · 11:58 AM EDT

Capricor Therapeutics (CAPR) Capital Expenditures (2011 - 2026)

Updated

Capricor Therapeutics (CAPR) reported Capital Expenditures of $4.06 million for Q2 2026, compared with $287,738 a year earlier and down 20.7% from the prior quarter.

Analysis

Capricor Therapeutics (CAPR) Capital Expenditures (2011 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Capricor Therapeutics' Capital Expenditures came in at $10.91 million, up 548.5% year-over-year; for FY2025, it was $2.9 million, up 148.9% from FY2024.

  • Capital Expenditures has a five-year compound annual growth rate of 39.6% (FY2020 to FY2025).
  • By year, Capital Expenditures came in at $1.17 million in FY2024 (-11.0%), $1.31 million in FY2023 (-34.4%), $2 million in FY2022 (+67.2%) and $1.2 million in FY2021 (+118.5%).
  • Five-year quarterly Capital Expenditures spans a low of $9,145 in Q3 2024 and a high of $5.12 million in Q1 2026.
  • Year over year, Capital Expenditures gained in five of the last seven quarters, with growth averaging 219.7%.
  • The high point for year-over-year Capital Expenditures in five years was Q3 2025 (growth of 510.6%); the low point was Q3 2024 (a decline of 96.6%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $5.12 million (Q1 2026), $1.66 million (Q4 2025) and $55,843 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 1.32 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 322.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -763.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 112.20 Mn
10 Capricor Therapeutics 506.13 Mn 506.13 Mn - 4.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.06 Mn
Mar 31, 2026 5.12 Mn
Dec 31, 2025 1.66 Mn
Sep 30, 2025 55,843.00
Jun 30, 2025 287,738.00
Mar 31, 2025 896,007.00
Dec 31, 2024 488,798.00
Sep 30, 2024 9,145.00
Jun 30, 2024 60,340.00
Mar 31, 2024 608,588.00
Dec 31, 2023 558,604.00
Sep 30, 2023 269,493.00
Jun 30, 2023 135,873.00
Mar 31, 2023 347,690.00
Dec 31, 2022 694,044.00
Sep 30, 2022 557,624.00
Jun 30, 2022 180,959.00
Mar 31, 2022 567,616.00
Dec 31, 2021 368,671.00
Sep 30, 2021 468,244.00
API Access

Capricor Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CAPR&period=max&api_key=YOUR_API_KEY